AAAAAA

   
Results: 1-15 |
Results: 15
SYNERGISTIC ANTICANCER EFFECTS OF GANCICLOVIR THYMIDINE KINASE AND 5-FLUOROCYTOSINE/CYTOSINE DEAMINASE GENE THERAPIES/
Authors: AGHI M KRAMM CM CHOU TC BREAKEFIELD XO CHIOCCA EA
Citation: M. Aghi et al., SYNERGISTIC ANTICANCER EFFECTS OF GANCICLOVIR THYMIDINE KINASE AND 5-FLUOROCYTOSINE/CYTOSINE DEAMINASE GENE THERAPIES/, Journal of the National Cancer Institute, 90(5), 1998, pp. 370-380
NEW PRODRUG ACTIVATION GENE-THERAPY FOR CANCER USING CYTOCHROME-P450 4B1 AND 2-AMINOANTHRACENE 4-IPOMEANOL/
Authors: RAINOV NG DOBBERSTEIN KU SENAESTEVES M HERRLINGER U KRAMM CM PHILPOT RM HILTON J CHIOCCA EA BREAKEFIELD XO
Citation: Ng. Rainov et al., NEW PRODRUG ACTIVATION GENE-THERAPY FOR CANCER USING CYTOCHROME-P450 4B1 AND 2-AMINOANTHRACENE 4-IPOMEANOL/, Human gene therapy, 9(9), 1998, pp. 1261-1273
PREEXISTING HERPES-SIMPLEX VIRUS-1 (HSV-1) IMMUNITY DECREASES, BUT DOES NOT ABOLISH, GENE-TRANSFER TO EXPERIMENTAL BRAIN-TUMORS BY A HSV-1 VECTOR
Authors: HERRLINGER U KRAMM CM ABOODYGUTERMAN KS SILVER JS IKEDA K JOHNSTON KM PECHAN PA BARTH RF FINKELSTEIN D CHIOCCA EA LOUIS DN BREAKEFIELD XO
Citation: U. Herrlinger et al., PREEXISTING HERPES-SIMPLEX VIRUS-1 (HSV-1) IMMUNITY DECREASES, BUT DOES NOT ABOLISH, GENE-TRANSFER TO EXPERIMENTAL BRAIN-TUMORS BY A HSV-1 VECTOR, Gene therapy, 5(6), 1998, pp. 809-819
LONG-TERM SURVIVAL IN A RODENT BRAIN-TUMOR MODEL BY BRADYKININ-ENHANCED INTRAARTERIAL DELIVERY OF A THERAPEUTIC HERPES-SIMPLEX VIRUS VECTOR
Authors: RAINOV NG DOBBERSTEIN KU HEIDECKE V DORANT U CHASE M KRAMM CM CHIOCCA EA BREAKEFIELD XO
Citation: Ng. Rainov et al., LONG-TERM SURVIVAL IN A RODENT BRAIN-TUMOR MODEL BY BRADYKININ-ENHANCED INTRAARTERIAL DELIVERY OF A THERAPEUTIC HERPES-SIMPLEX VIRUS VECTOR, Cancer gene therapy, 5(3), 1998, pp. 158-162
THERAPEUTIC EFFICIENCY AND SAFETY OF A 2ND-GENERATION REPLICATION-CONDITIONAL HSV1 VECTOR FOR BRAIN-TUMOR GENE-THERAPY
Authors: KRAMM CM CHASE M HERRLINGER U JACOBS A PECHAN PA RAINOV NG SENAESTEVES M AGHI M BARNETT FH CHIOCCA EA BREAKEFIELD XO
Citation: Cm. Kramm et al., THERAPEUTIC EFFICIENCY AND SAFETY OF A 2ND-GENERATION REPLICATION-CONDITIONAL HSV1 VECTOR FOR BRAIN-TUMOR GENE-THERAPY, Human gene therapy, 8(17), 1997, pp. 2057-2068
VACCINATION FOR EXPERIMENTAL GLIOMAS USING GM-CSF-TRANSDUCED GLIOMA-CELLS
Authors: HERRLINGER U KRAMM CM JOHNSTON KM LOUIS DN FINKELSTEIN D REZNIKOFF G DRANOFF G BREAKEFIELD XO YU JS
Citation: U. Herrlinger et al., VACCINATION FOR EXPERIMENTAL GLIOMAS USING GM-CSF-TRANSDUCED GLIOMA-CELLS, Cancer gene therapy, 4(6), 1997, pp. 345-352
CIRCULATING CD34(-CELL APHERESIS IN EWING TUMOR PATIENTS() CELL COUNTS AS PREDICTIVE PARAMETER FOR THE EFFICACY OF PERIPHERAL STEM)
Authors: ENGEL BC LAWS HJ DIRKSEN U KRAMM CM GOBEL U BURDACH SEG
Citation: Bc. Engel et al., CIRCULATING CD34(-CELL APHERESIS IN EWING TUMOR PATIENTS() CELL COUNTS AS PREDICTIVE PARAMETER FOR THE EFFICACY OF PERIPHERAL STEM), Klinische Padiatrie, 209(4), 1997, pp. 186-190
HERPES VECTOR-MEDIATED DELIVERY OF MARKER GENES TO DISSEMINATED CENTRAL-NERVOUS-SYSTEM TUMORS
Authors: KRAMM CM RAINOV NG SENAESTEVES M CHASE M PECHAN PA CHIOCCA EA BREAKEFIELD XO
Citation: Cm. Kramm et al., HERPES VECTOR-MEDIATED DELIVERY OF MARKER GENES TO DISSEMINATED CENTRAL-NERVOUS-SYSTEM TUMORS, Human gene therapy, 7(3), 1996, pp. 291-300
LONG-TERM SURVIVAL IN A RODENT MODEL OF DISSEMINATED BRAIN-TUMORS BY COMBINED INTRATHECAL DELIVERY OF HERPES VECTORS AND GANCICLOVIR TREATMENT
Authors: KRAMM CM RAINOV NG SENAESTEVES M BARNETT FH CHASE M HERRLINGER U PECHAN PA CHIOCCA EA BREAKEFIELD XO
Citation: Cm. Kramm et al., LONG-TERM SURVIVAL IN A RODENT MODEL OF DISSEMINATED BRAIN-TUMORS BY COMBINED INTRATHECAL DELIVERY OF HERPES VECTORS AND GANCICLOVIR TREATMENT, Human gene therapy, 7(16), 1996, pp. 1989-1994
RETROVIRUS-MEDIATED GENE-THERAPY OF EXPERIMENTAL BRAIN NEOPLASMS USING THE HERPES-SIMPLEX VIRUUS THYMIDINE KINASE GANCICLOVIR PARADIGM
Authors: RAINOV NG KRAMM CM ABOODYGUTERMAN K CHASE M UEKI K LOUIS DN HARSH GR CHIOCCA A BREAKEFIELD XO
Citation: Ng. Rainov et al., RETROVIRUS-MEDIATED GENE-THERAPY OF EXPERIMENTAL BRAIN NEOPLASMS USING THE HERPES-SIMPLEX VIRUUS THYMIDINE KINASE GANCICLOVIR PARADIGM, Cancer gene therapy, 3(2), 1996, pp. 99-106
SELECTIVE UPTAKE OF VIRAL AND MONOCRYSTALLINE PARTICLES DELIVERED INTRAARTERIALLY TO EXPERIMENTAL BRAIN NEOPLASMS
Authors: RAINOV NG ZIMMER C CHASE M KRAMM CM CHIOCCA EA WEISSLEDER R BREAKEFIELD XO
Citation: Ng. Rainov et al., SELECTIVE UPTAKE OF VIRAL AND MONOCRYSTALLINE PARTICLES DELIVERED INTRAARTERIALLY TO EXPERIMENTAL BRAIN NEOPLASMS, Human gene therapy, 6(12), 1995, pp. 1543-1552
GENE-THERAPY FOR BRAIN-TUMORS
Authors: KRAMM CM SENAESTEVES M BARNETT FH RAINOV NG SCHUBACK DE YU JS PECHAN PA PAULUS W CHIOCCA EA BREAKEFIELD XO
Citation: Cm. Kramm et al., GENE-THERAPY FOR BRAIN-TUMORS, Brain pathology, 5(4), 1995, pp. 345-381
NEURON-SPECIFIC EXPRESSION OF THE NORRIE DISEASE GENE (NDP) IN THE CENTRAL-NERVOUS-SYSTEM
Authors: CHEN ZY KRAMM CM BATTINELLI EM LI F SCHUBACK DE COREY DP
Citation: Zy. Chen et al., NEURON-SPECIFIC EXPRESSION OF THE NORRIE DISEASE GENE (NDP) IN THE CENTRAL-NERVOUS-SYSTEM, American journal of human genetics, 57(4), 1995, pp. 747-747
LONG-TERM SURVIVAL OF RATS HARBORING BRAIN NEOPLASMS TREATED WITH GANCICLOVIR AND A HERPES-SIMPLEX VIRUS VECTOR THAT RETAINS AN INTACT THYMIDINE KINASE GENE
Authors: BOVIATSIS EJ PARK JS SENAESTEVES M KRAMM CM CHASE M EFIRD JT WEI MX BREAKEFIELD XO CHIOCCA EA
Citation: Ej. Boviatsis et al., LONG-TERM SURVIVAL OF RATS HARBORING BRAIN NEOPLASMS TREATED WITH GANCICLOVIR AND A HERPES-SIMPLEX VIRUS VECTOR THAT RETAINS AN INTACT THYMIDINE KINASE GENE, Cancer research, 54(22), 1994, pp. 5745-5751
ROD-OPSIN IMMUNOREACTION IN THE PINEAL ORGAN OF THE PIGMENTED MOUSE DOES NOT INDICATE THE PRESENCE OF A FUNCTIONAL PHOTOPIGMENT
Authors: KRAMM CM DEGRIP WJ KORF HW
Citation: Cm. Kramm et al., ROD-OPSIN IMMUNOREACTION IN THE PINEAL ORGAN OF THE PIGMENTED MOUSE DOES NOT INDICATE THE PRESENCE OF A FUNCTIONAL PHOTOPIGMENT, Cell and tissue research, 274(1), 1993, pp. 71-78
Risultati: 1-15 |